Pfizer, AZ jabs induce lower antibodies vs Omicron

Monday, 13. December 2021 11:06

Two dose COVID-19 vaccines developed by Pfizer/BioNTech and AstraZeneca induce a lower amount of antibodies against the Omicron coronavirus strain compared to previous variants, according to an Oxford study published on Monday.

The research, yet to be peer-reviewed, however found no evidence that the lower antibody level could lead to a higher risk of severe COVID-19 or death.

Commenting on the results, the paper's co-author Matthew Snape noted that "these data are important but are only one part of the picture. They only look at neutralizing antibodies after the second dose, but do not tell us about cellular immunity, and this will also be tested."

Related Links: AstraZeneca plcBioNTech SEPfizer Inc.
Baha Breaking News (BBN) / ND